Researchers explore new treatments for a leading genetic cause of infant deaths

July 19, 2013

Researchers at Iowa State University have identified an RNA structure in humans that could lead to a new treatment for spinal muscular atrophy, the leading genetic cause of death in babies and young children.

Ravindra Singh, a professor of in the ISU College of Veterinary Medicine, is the lead author of a paper published this week in the journal Nucleic Acids Research that details the discovery of a novel that could be modified by medication, leading to new treatment possibilities for the disease.

Spinal results from the loss or mutation of a gene called Survival Motor Neuron 1, often referred to as SMN1. If SMN1 is deleted or doesn't function properly, not enough SMN protein is produced, giving rise to the disease.

Luckily, the vast majority of humans have a nearly identical gene, referred to as SMN2, which can function as a substitute. But a critical portion of SMN2 is sometimes erroneously removed during the process known as splicing, or when pre-mRNA is turned into mRNA by getting rid of non-functioning parts of the gene.

In the new paper, Singh and his colleagues have discovered an RNA structure exclusively formed by intronic sequences, or sequences that are removed during splicing. By targeting that structure, it may be possible to develop new treatments that prevent the mistake in the splicing process that causes the loss of function of SMN2, Singh said. If so, this is the first time a deep intronic structure can be targeted for therapy.

"About a quarter of a person's genome is made up of introns, or non-coding sequences, that must be removed through splicing throughout life," Singh said. "We've found an RNA structure that aberrantly promotes the escape of one of the coding sequences through splicing."

Singh cautioned that development of a new treatment would have to go through years of and further study, but the bottom line is that the research could result in a new way to cure . In fact, private companies have shown interest in negotiating with Iowa State to begin development of a drug based on the research, Singh said.

He said the paper required about five years of painstaking work, testing hundreds of to individual gene sequences one at a time to see if they have an effect on splicing.

"The process involves a lot of trial and error," he said.

Studying RNA structures within the non-coding portion of the human is still a relatively untouched frontier with much left to teach us, Singh said. It appears that RNA structures hold enormous information, and new techniques for studying RNA structures are unlocking new possibilities that could have major implications for how we treat genetic diseases, he said.

"In many ways this is still a very poorly understood field," Singh said. "But around half of all genetic diseases are a result of errors in splicing, so we have much to gain from answering these questions."

Explore further: Molecular Therapy for Spinal Muscular Atrophy Closer to Clinical Use

More information: nar.oxfordjournals.org/content/early/2013/07/14/nar.gkt609.full

Related Stories

Dark matter made visible before the final cut

January 7, 2013

Research findings from the University of North Carolina School of Medicine are shining a light on an important regulatory role performed by the so-called dark matter, or "junk DNA," within each of our genes.

Recommended for you

Basic research fuels advanced discovery

August 26, 2016

Clinical trials and translational medicine have certainly given people hope and rapid pathways to cures for some of mankind's most troublesome diseases, but now is not the time to overlook the power of basic research, says ...

New method creates endless supply of kidney precursor cells

August 25, 2016

Salk Institute scientists have discovered the holy grail of endless youthfulness—at least when it comes to one type of human kidney precursor cell. Previous attempts to maintain cultures of the so-called nephron progenitor ...

New avenue for understanding cause of common diseases

August 25, 2016

A ground-breaking Auckland study could lead to discoveries about many common diseases such as diabetes, cancer and dementia. The new finding could also illuminate the broader role of the enigmatic mitochondria in human development.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.